Life Science & Digital
The LOTTE Group is accelerating business transformation in the life science and digital sectors — key drivers of our future growth. We are actively expanding our capabilities across biopharmaceutical CDMO services, corporate venture capital (CVC), high-performance materials, and clean energy solutions utilizing hydrogen and ammonia. Additionally, we are rapidly advancing our IT and digital ventures, including AI and EV infrastructure. By driving innovation through cutting-edge technology and the collective strengths of the LOTTE Group, we aim to enhance global well-being and build a sustainable society.
Biopharmaceuticals
Healthcare and Biopharmaceutical CVC
(Corporate Venture Capital)
Through our healthcare and biopharmaceutical CVC, we invest in global startups that possess innovative technologies, including antibody drugs, antibody-drug conjugates (ADCs), next-generation modalities, and medical devices. In addition to capital, we leverage the LOTTE Group's comprehensive assets—including manufacturing support from LOTTE BIOLOGICS—to accelerate the growth of our portfolio companies and pioneer breakthrough medical solutions.
Providers:LOTTE HOLDINGS
CDMO(Contract Development and Manufacturing Organization)
Since 2022, we have been scaling our global CDMO business. Our Syracuse biocampus in the US provides premier manufacturing services for high-quality antibody drug substances and ADCs. Furthermore, in Songdo, Korea, we are constructing a state-of-the-art biocampus with a production capacity of 120,000 liters that is scheduled to commence operations in 2027.
Providers:LOTTE BIOLOGICS
Fine and Advanced Chemicals
Fine Chemicals
We have a green materials business featuring AnyCoat®, our plant-based capsule material, and AnyAddy®, our physical property modifier. Alongside this, our fine chemical business produces essential components, including ammonia and raw materials for semiconductors and electronic displays. By continuously refining our high-value-added, proprietary technologies, we are strengthening our global competitiveness and driving sustainable growth.
Providers:LOTTE FINE CHEMICAL
Advanced Chemicals
From our operational bases in Korea, we supply a diverse array of synthetic resins and chemical products for construction and interior applications. In Japan, we specialize in high-performance plastics for automobiles and home appliances, alongside artificial marble and other premium building materials. Moving forward, we remain committed to delivering advanced chemical solutions that support both industry and daily life.
Providers:LOTTE Chemical
Hydrogen / Ammonia
Hydrogen / Ammonia Value Chain
The LOTTE Group boasts Asia's leading distribution infrastructure and is actively building a clean energy supply network utilizing ammonia as a hydrogen carrier. Our major hub, the Ulsan ammonia storage facility in Korea, provides a strategic geographical advantage, located just 230km from Kitakyushu, Japan. This Ulsan facility serves as the cornerstone of an efficient hydrogen and ammonia value chain, driving the realization of a decarbonized society.
Providers:LOTTE Chemical, LOTTE FINE CHEMICAL
IT / Digital
Digital Transformation (DX)
The LOTTE Group provides a comprehensive range of digital transformation (DX) solutions, spanning from initial strategy formulation to system architecture. By combining advanced technologies—such as AI, big data, and robotics—with our deep industry expertise, we drive innovation in smart factories, logistics automation, and next-generation retail. Ultimately, we accelerate our clients' business transformations to create lasting value.
Providers:LOTTE Innovate
EV Chargers
Leveraging our expertise in ultra-fast charger manufacturing technology, we are actively expanding our EV charging infrastructure business globally. In Japan, we launched our first domestic raid charger in Osaka in April 2025. Through the widespread installation of high-performance chargers, the LOTTE Group will continue to develop and advance the EV ecosystem and support the future of mobility.
Providers:EVSIS